Inventiva S.A. American Depository Shares
IVA Real Time Price USDRecent trades of IVA by members of U.S. Congress
No Congress Trading data for this ticker
Congress Trading Dashboard
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by IVA's directors and management
No recent Insider Trading for this ticker
Insider Trading DashboardGovernment lobbying spending instances
No Corporate Lobbying instances for this ticker
Corporate Lobbying DashboardEstimated quarterly lobbying spending
No Corporate Lobbying data for this ticker
Corporate Lobbying DashboardNew patents grants
-
Patent Title: Inhibitors of the yap/taz-tead interaction and their use in the treatment of cancer Jun. 04, 2024
-
Patent Title: Method of treatment of cirrhosis Nov. 22, 2022
-
Patent Title: Compounds as inhibitors of the yap/taz-tead interaction and their use in the treatment of malignant mesothelioma Sep. 17, 2019
-
Patent Title: Ppar compounds for use in the treatment of fibrotic diseases Aug. 20, 2019
-
Patent Title: Method of treatment of a mucopolysaccharidosis Oct. 09, 2018
-
Patent Title: Ppar compounds for use in the treatment of fibrotic diseases Aug. 21, 2018
-
Patent Title: Use of odiparcil in the treatment of a mucopolysaccharidosis Feb. 07, 2017
Federal grants, loans, and purchases
No Government Contracts for this ticker
Government Contracts DashboardEstimated quarterly amount awarded from public contracts
Number of mentions of IVA in WallStreetBets Daily Discussion
Recent insights relating to IVA
Recent picks made for IVA stock on CNBC
ETFs with the largest estimated holdings in IVA
Shareholder
|
Shares Held
|
---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view IVA Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.